Last reviewed · How we verify
Bryophyllum 50 % Chewing Tablets — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Bryophyllum 50 % Chewing Tablets (Bryophyllum 50 % Chewing Tablets) — Markus Schlemmer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bryophyllum 50 % Chewing Tablets TARGET | Bryophyllum 50 % Chewing Tablets | Markus Schlemmer | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bryophyllum 50 % Chewing Tablets CI watch — RSS
- Bryophyllum 50 % Chewing Tablets CI watch — Atom
- Bryophyllum 50 % Chewing Tablets CI watch — JSON
- Bryophyllum 50 % Chewing Tablets alone — RSS
Cite this brief
Drug Landscape (2026). Bryophyllum 50 % Chewing Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/bryophyllum-50-chewing-tablets. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab